Georgi Dzhupanov,
"Cholinesterase inhibitors should not be recommended for mild cognitive impairment."
"Cholinesterase inhibitors should not be recommended for mild cognitive impairment."
PubMed comprises more than 22 million citations for biomedical literature from MEDLINE, life science journals, and online books.
New evidence suggests that Cholinesterase inhibitors (like donepezil) should not be recommended for Mild Cognitive Impairment